Tools

Lung Cancers

Lung cancer is cancer that starts in the lungs. It is one of the most common cancers in the world and is a leading cause of cancer death in men and women in the United States. It can be caused by cigarette smoking, but not always.

Programs + Services


Thoracic Cancer Program

Find information on the Thoracic Cancer Program at Tufts Medical Center in Boston and learn more about treatment options for lung and chest tumors.
More


Lung Cancer Clinic

The Lung Cancer Clinic at Tufts Medical Center provides a comprehensive and individualized approach to treating all stages of lung cancer with targeted therapies and minimally invasive surgery.
More

Doctors + Care Team

Barbara J. Weinstein, MD

Barbara J. Weinstein, MD

Title(s): Staff Pathologist; Assistant Professor, Tufts University School of Medicine
Department(s): Pathology and Laboratory Medicine
Appt. Phone: 617-636-5829
Fax #: 617-636-8302

General surgical pathology, cytopathology, gastrointestinal pathology

More Info

Gary M. Strauss, MD, MPH

Gary M. Strauss, MD, MPH

Title(s): Medical Director, Lung Cancer Program; Professor, Tufts University School of Medicine
Department(s): Medicine, Hematology/Oncology
Appt. Phone: 617-636-6227
Fax #: 617-636-8538

Lung cancer, melanoma, breast cancer, genitourinary cancer, solid tumors

More Info

Greg L. Schumaker, MD

Greg L. Schumaker, MD

Title(s): Medical Director, Lowell General Hospital ICU; Director, Rapid Response Team; Director, Clinical Resource Nurse Program; Assistant Professor, Tufts University School of Medicine
Department(s): Medicine, Pulmonary, Critical Care and Sleep Medicine
Appt. Phone: 617-636-6377
Fax #: 617-636-1649

Pulmonary diseases, critical care medicine, sleep medicine

More Info

John E. Mignano, MD, PhD

John E. Mignano, MD, PhD

Title(s): Radiation Oncologist; Clinic Director; Associate Professor, Tufts University School of Medicine
Department(s): Radiation Oncology, Pediatric Radiation Oncology
Appt. Phone: 617-636-6161
Fax #: 617-636-4513

Oncologic consultation for general radiotherapy and Gamma Knife, pediatric radiation oncology

More Info

Kari E. Roberts, MD

Kari E. Roberts, MD

Title(s): Director, Bronchoscopy Service; Associate Program Director, Internal Medicine Residency; Associate Professor, Tufts University School of Medicine
Department(s): Medicine, Pulmonary, Critical Care and Sleep Medicine
Appt. Phone: 617-636-6377
Fax #: 617-636-1649

General pulmonology, pulmonary hypertension, critical care medicine

More Info

Kathryn Huber, MD, PhD

Kathryn Huber, MD, PhD

Title(s): Radiation Oncologist; Assistant Professor, Tufts University School of Medicine
Department(s): Radiation Oncology
Appt. Phone: 617-636-6161
Fax #: 617-636-6131

Radiotherapy for cancers of the lung and gastrointestinal tract

More Info

Laurence H. Brinckerhoff, MD

Laurence H. Brinckerhoff, MD

Title(s): Surgeon; Associate Professor, Tufts University School of Medicine
Department(s): Surgery, General Surgery, Thoracic Surgery
Appt. Phone: 617-636-5589
Fax #: 617-636-9095

Thoracic surgical oncology, minimally invasive surgery, clinical trials, tumor immunology

More Info

Lori Pai, MD

Lori Pai, MD

Title(s): Medical Oncologist
Department(s): Medicine, Hematology/Oncology
Appt. Phone: 617-636-6227
Fax #: 617-636-8538

Thoracic oncology, melanoma

More Info

Maher Tabba, MD

Maher Tabba, MD

Title(s): Fellowship Director; Assistant Professor, Tufts University School of Medicine
Department(s): Medicine, Pulmonary, Critical Care and Sleep Medicine
Appt. Phone: 617-636-6377
Fax #: 617-636-1649

Interventional pulmonology, thoracic oncology, general pulmonology

More Info

Neil J. Halin, DO, FSIR

Neil J. Halin, DO, FSIR

Title(s): Chief, Cardiovascular and Interventional Radiology; Assistant Professor, Tufts University School of Medicine
Department(s): Radiology, CardioVascular Center
Appt. Phone: 617-636-3004
Fax #: 617-636-1449

Peripheral vascular disease, biliary and urinary obstruction, thrombo-embolic disease, vascular disease, general radiology

More Info

Research + Clinical Trials


RTOG 1306: A Randomized Phase II Study of Individualized Combined Modality Therapy for Stage III Non-small Cell Lung Cancer (NSCLC)

Cancer is a disease caused by alterations in the functions of genes within the cells. In approximately 15% of patients with non-small cell lung cancer, one of two genes is altered significantly (known as EGFR mutation or ALK rearrangement). Erlotinib, a pill, taken on a daily basis produces significant decrease in the size of tumors in patients with advanced stage lung cancer with EGFR mutation. Similarly, another pill, crizotinib, produces significant decrease in the size of tumors in patients with advanced stage lung cancer with ALK rearrangement. However it is not clear how useful these two drugs will be in patients with a less advanced form of lung cancer in the presence of these gene alterations.  The purpose of this study is to find out what effects, good and/or bad, one of the following treatments has on locally advanced, non-operable lung cancer with specific gene alterations (EGFR mutation or ALK rearrangement).
More


An Open-label, Randomized Phase 3 Efficacy Study of ASP8273 vs Erlotinib or Gefitinib in First-line Treatment of Patients with Stage IIIB/IV Non-small Cell Lung Cancer Tumors with EGFR Activating Mutations SOLAR Study

The purpose of the study is to collect information to determine if an investigational drug called ASP8273 is effective, safe and comparable to the treatments erlotinib or gefitinib that are already approved in the US, Europe and Asia, respectively, for patients with your type of NSCLC.
More


Phase 2, Parallel-Arm Study of MGCD265 in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Activating Genetic Alterations in Mesenchymal- Epithelial Transition Factor

The main purpose of this study is to test whether subjects with lung cancer, with specific changes in the tumor genes, benefit from getting study drug, MGCD265.  Other objectives of the study include assessing the side effects of MGCD265 in subjects, and how much and how quickly drug is absorbed and cleared from the blood stream.
More

Tufts Medical Center and Floating Hospital for Children have high quality care.

Quality + Safety

A world-class teaching hospital shouldn’t make you feel small.  At Tufts Medical Center the patient is at the center of everything that we do.  This means we’re committed to providing the highest quality of care in a safe, friendly environment.

Learn more
The City of Boston.

200 Years of Caring for the Community

Tufts Medical Center has been taking care of Boston and the surrounding community for more than 200 years.

Read about our enduring history